Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

448 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of regulatory factor X1 can predict the prognosis of breast cancer.
Shibata M, Kanda M, Shimizu D, Tanaka H, Umeda S, Hayashi M, Inaishi T, Miyajima N, Adachi Y, Takano Y, Nakanishi K, Takeuchi D, Noda S, Kodera Y, Kikumori T. Shibata M, et al. Among authors: shimizu d. Oncol Lett. 2017 Jun;13(6):4334-4340. doi: 10.3892/ol.2017.6005. Epub 2017 Apr 7. Oncol Lett. 2017. PMID: 28599435 Free PMC article.
Reduced expression of DENND2D through promoter hypermethylation is an adverse prognostic factor in squamous cell carcinoma of the esophagus.
Hibino S, Kanda M, Oya H, Takami H, Shimizu D, Nomoto S, Hishida M, Niwa Y, Koike M, Yamada S, Nishikawa Y, Asai M, Nakayama G, Fujii T, Sugimoto H, Fujiwara M, Kodera Y. Hibino S, et al. Among authors: shimizu d. Oncol Rep. 2014 Feb;31(2):693-700. doi: 10.3892/or.2013.2901. Epub 2013 Dec 5. Oncol Rep. 2014. PMID: 24317529
Prognostic impact of expression and methylation status of DENN/MADD domain-containing protein 2D in gastric cancer.
Kanda M, Shimizu D, Nomoto S, Takami H, Hibino S, Oya H, Hashimoto R, Suenaga M, Inokawa Y, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: shimizu d. Gastric Cancer. 2015 Apr;18(2):288-96. doi: 10.1007/s10120-014-0372-0. Epub 2014 Apr 3. Gastric Cancer. 2015. PMID: 24695972
Dihydropyrimidinase-like 3 facilitates malignant behavior of gastric cancer.
Kanda M, Nomoto S, Oya H, Shimizu D, Takami H, Hibino S, Hashimoto R, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: shimizu d. J Exp Clin Cancer Res. 2014 Aug 6;33(1):66. doi: 10.1186/s13046-014-0066-9. J Exp Clin Cancer Res. 2014. PMID: 25096402 Free PMC article.
Dihydropyrimidinase-like 3 is a putative hepatocellular carcinoma tumor suppressor.
Oya H, Kanda M, Sugimoto H, Shimizu D, Takami H, Hibino S, Hashimoto R, Okamura Y, Yamada S, Fujii T, Nakayama G, Koike M, Nomoto S, Fujiwara M, Kodera Y. Oya H, et al. Among authors: shimizu d. J Gastroenterol. 2015 May;50(5):590-600. doi: 10.1007/s00535-014-0993-4. Epub 2014 Aug 31. J Gastroenterol. 2015. PMID: 25173447
Decreased expression of prenyl diphosphate synthase subunit 2 correlates with reduced survival of patients with gastric cancer.
Kanda M, Nomoto S, Oya H, Hashimoto R, Takami H, Shimizu D, Sonohara F, Kobayashi D, Tanaka C, Yamada S, Fujii T, Nakayama G, Sugimoto H, Koike M, Murotani K, Fujiwara M, Kodera Y. Kanda M, et al. Among authors: shimizu d. J Exp Clin Cancer Res. 2014 Oct 22;33(1):88. doi: 10.1186/s13046-014-0088-3. J Exp Clin Cancer Res. 2014. PMID: 25330808 Free PMC article.
448 results